Literature DB >> 6939922

Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.

R G Croy, G N Wogan.   

Abstract

The covalent interactions between aflatoxin B1 (AFB1) and DNA were investigated in the inbred F344 rat and noninbred CD -1 Swiss mouse. A good correlation was found between the level of covalent modification of DNA, species sensitivity, and organ specificity, to the toxic effects of AFB1. The patterns of AFB1 acid hydrolysis products from DNA isolated from the livers and kidneys of both species were examined. The principal acid hydrolysis product in all cases was identified as 2,3-dihydro-3-hydroxy-(N7-guanyl)AFB1. Minor products consisted of adducts formed by the chemical transformation of the AFB1-N7-substituted guanine moiety forming putative formamidopyrimidine derivatives and the activation of AFB1 metabolites, which also modified the N-7 guanine atom. These last-mentioned products were present in greater amounts in resistant tissues. In vitro studies on the activation of AFB1 by microsomal fractions of mouse and rat livers found that mouse liver microsomes were rapidly inactivated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6939922

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  The formamidopyrimidine derivative of 7-(2-oxoethyl)-2'-deoxyguanosine.

Authors:  Plamen P Christov; Ivan D Kozekov; Carmelo J Rizzo; Thomas M Harris
Journal:  Chem Res Toxicol       Date:  2008-08-09       Impact factor: 3.739

2.  Intercellular variation in levels of adducts of aflatoxin B1 and G1 in DNA from rat tissues: a quantitative immunocytochemical study.

Authors:  C P Wild; R Montesano; J Van Benthem; E Scherer; L Den Engelse
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  In vitro microsome-mediated aflatoxin B1-DNA binding and its inhibition by cytosol of various organs of the hamster and quail.

Authors:  M Kono; S Kumagai
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

Review 4.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

Review 5.  Nucleic acid adducts of chemical carcinogens and mutagens.

Authors:  K Hemminki
Journal:  Arch Toxicol       Date:  1983-04       Impact factor: 5.153

6.  A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site.

Authors:  E A Bailey; R S Iyer; T M Harris; J M Essigmann
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

7.  The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.

Authors:  Maryann E Smela; Michelle L Hamm; Paul T Henderson; Constance M Harris; Thomas M Harris; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

8.  Mutational properties of the primary aflatoxin B1-DNA adduct.

Authors:  E A Bailey; R S Iyer; M P Stone; T M Harris; J M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli.

Authors:  P L Foster; J D Groopman; E Eisenstadt
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

10.  Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1.

Authors:  Zoran Ilic; Dana Crawford; Dilip Vakharia; Patricia A Egner; Stewart Sell
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-20       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.